Oral Ribavirin with or without the Addition of Immune Globulin for the Treatment of Lower Respiratory Tract Infections Due to Respiratory Syncytial Virus or Parainfluenza in Patients after Allogeneic Stem Cell Transplantation

被引：1
|
作者：
Stamouli, Maria [1 ]
Tsonis, Ioannis [2 ]
Gkirkas, Konstantinos [1 ]
Economopoulou, Christina [3 ]
Thomopoulos, Thomas [1 ]
Paisiou, Anna [3 ]
Siafakas, Nikolaos [1 ]
Pournaras, Spyridon [1 ]
Antoniadou, Anastasia [1 ]
Karagiannidi, Aggeliki [1 ]
Meletiadis, Joseph [1 ]
Kavatha, Dimitra [1 ]
Vassilopoulos, George [4 ]
Gigantes, Stavros [5 ]
Baltadakis, Ioannis [5 ]
Goussetis, Evgenios [3 ]
Karakasis, Dimitrios [6 ]
Tsirigotis, Panagiotis [1 ]
机构：
[1] Natl & Kapodistrian Univ Athens, ATTIKON Univ Hosp, Athens, Greece
[2] Evangelismos Gen Hosp, Viron, Greece
[3] Aghia Sophia Children Hosp, Athens, Greece
[4] Univ Thessaly Med Sch, Dept Hematol, Larisa, Greece
[5] Evangelismos Gen Hosp, Dept Haematol & Bone Marrow Transplantat Unit, Athens, Greece
[6] Evangelismos Gen Hosp, Athens, Greece
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-128362
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4498
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients
    Foolad, Farnaz
    Aitken, Samuel L.
    Shigle, Terri Lynn
    Prayag, Amrita
    Ghantoji, Shashank
    Ariza-Heredia, Ella
    Chemaly, Roy F.
    CLINICAL INFECTIOUS DISEASES, 2019, 68 (10) : 1641 - 1649
  • [32] EFFECTIVE USE OF ORAL RIBAVIRIN FOR RESPIRATORY SYNCYTIAL VIRAL INFECTIONS IN ADULT ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
    Gorcea, C. M.
    Tholouli, E.
    Turner, A.
    Davies, E.
    Battersby, E.
    Saif, M.
    Dignan, F.
    HAEMATOLOGICA, 2016, 101 : 634 - 634
  • [33] Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients
    Marcelin, J. R.
    Wilson, J. W.
    Razonable, R. R.
    TRANSPLANT INFECTIOUS DISEASE, 2014, 16 (02) : 242 - 250
  • [34] The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation
    AJ McCarthy
    HM Kingman
    C Kelly
    GS Taylor
    EO Caul
    D Grier
    J Moppett
    ABM Foot
    JM Cornish
    A Oakhill
    CG Steward
    DH Pamphilon
    DI Marks
    Bone Marrow Transplantation, 1999, 24 : 1315 - 1322
  • [35] The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation
    McCarthy, AJ
    Kingman, HM
    Kelly, C
    Taylor, GS
    Caul, EO
    Grier, D
    Moppett, J
    Foot, ABM
    Cornish, JM
    Oakhill, A
    Steward, CG
    Pamphilon, DH
    Marks, DI
    BONE MARROW TRANSPLANTATION, 1999, 24 (12) : 1315 - 1322
  • [36] Respiratory syncytial virus infections following allogeneic haematopoetic stem cell transplantation:: palivizumab as a new promising approach for combination therapy with ribavirin and immunoglobulin?
    Fritsch, S.
    Bergmann, M.
    Mumm, F.
    Jaeger, G.
    Ledderose, G.
    Tischer, J.
    Kolb, H. J.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S281 - S281
  • [37] Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections
    Shah, Dimpy P.
    Ghantoji, Shashank S.
    Shah, Jharna N.
    El Taoum, Katia K.
    Jiang, Ying
    Popat, Uday
    Hosing, Chitra
    Rondon, Gabriela
    Tarrand, Jeffrey J.
    Champlin, Richard E.
    Chemaly, Roy F.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (08) : 1872 - 1880
  • [38] Are We Overlooking the Use of Oral Ribavirin for Respiratory Syncytial Virus Infection Following Hematopoietic Stem Cell Transplantation?
    Assi, Mariam
    Cornfield, Brittany
    Engracia, Dominic
    Chung, Harold
    Clark, William
    McCarty, John
    Silveira, Fernanda P.
    Roberts, Catherine
    Toor, Amir
    De la Cruz, Oveimar
    CURRENT TREATMENT OPTIONS IN INFECTIOUS DISEASES, 2019, 11 (02) : 188 - 198
  • [39] Are We Overlooking the Use of Oral Ribavirin for Respiratory Syncytial Virus Infection Following Hematopoietic Stem Cell Transplantation?
    Mariam Assi
    Brittany Cornfield
    Dominic Engracia
    Harold Chung
    William Clark
    John McCarty
    Fernanda P. Silveira
    Catherine Roberts
    Amir Toor
    Oveimar De la Cruz
    Current Treatment Options in Infectious Diseases, 2019, 11 : 188 - 198
  • [40] Respiratory syncytial virus infections (RVS) after allogeneic hematopoietic stem cell transplantation (HSCT) in the palivizumab (P) era.
    de Fontbrune, Flore Sicre
    Robin, Marie
    Scieux, Catherine
    de Latour, Regis Peffault
    Le Ferry, Christ
    Rocha, Vanderson
    Boudjedir, Karim
    Devergie, Agnes
    Gluckman, Eliane
    Socie, Gerard
    Ribaud, Patricia
    BLOOD, 2006, 108 (11) : 806A - 806A
12345